Key Statistics for SRDX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (09/2014)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SRDX
- Net Income (M/USD)
SurModics, Inc. provides surface modification solutions to the medical device industry. The Company's primary focus is the commercialization of its PhotoLink process through third-party licensing arrangements. SurModics's process is a light-activated coating technology that modifies medical device surfaces by creating chemical bonds between those surfaces and a variety of chemical agents.
More Company Profile & Key Executives for SRDX
|Scott R WardChairman||Gary R MaharajPresident/CEO|
|Charles W OlsonSenior VP/Gen Mgr:Medical Device||Bryan K PhillipsSenior VP:Legal/General Cnsl/Secy|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.